Literature DB >> 16839839

Transferrin and iron induce insulin resistance of glucose transport in adipocytes.

Allan Green1, Robin Basile, John M Rumberger.   

Abstract

Normal serum can increase the rate of lipolysis in isolated adipocytes. Recently, we reported that the lipolytic effect of serum could be partly explained by effects of iron and transferrin. To further investigate these effects on fat cell metabolism, we have investigated effects of serum, iron, and transferrin on glucose transport in isolated rat adipocytes. Adipocytes were isolated by collagenase digestion of rat epididymal fat pads, and glucose transport was measured as uptake of [3H]2-deoxyglucose, measured in the presence of 0 to 25 ng/mL insulin. Insulin stimulated glucose transport approximately 8- to 10-fold, with a half-maximally effective concentration (EC50) of approximately 0.15 ng/mL. This was not affected by 45-minute treatment with normal human serum. However, when adipocytes were incubated with serum for 4 hours, cells became markedly insulin resistant. This was manifested as decrease in maximally stimulated glucose transport and a rightward shift in the dose-response curve. Both FeS04 (3 microg/mL) and transferrin (100 microg/mL) had similar, although less pronounced effects on insulin-stimulated glucose transport. Treatment of adipocytes with palmitic acid (120 micromol/L), representing the concentration of fatty acids released into the media after 4 hours of serum treatment, did not alter the effect of insulin on glucose transport. We conclude that transferrin and iron induce insulin resistance of glucose transport in adipocytes through a mechanism independent of fatty acids. These findings may further explain the association between body iron stores and risk of type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839839     DOI: 10.1016/j.metabol.2006.03.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

1.  Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Malgorzata Lawniczak; Joanna Miezynska-Kurtycz; Jan Lubinski
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 2.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

3.  Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.

Authors:  Tatsuyori Morita; Daisuke Nakano; Kento Kitada; Satoshi Morimoto; Atsuhiro Ichihara; Hirofumi Hitomi; Hiroyuki Kobori; Ichiro Shiojima; Akira Nishiyama
Journal:  Eur J Pharmacol       Date:  2015-03-26       Impact factor: 4.432

Review 4.  Surgical Mouse Models of Vertical Sleeve Gastrectomy and Roux-en Y Gastric Bypass: a Review.

Authors:  Matthew Stevenson; Jenny Lee; Raymond G Lau; Collin E M Brathwaite; Louis Ragolia
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 5.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

6.  Adipocyte iron regulates adiponectin and insulin sensitivity.

Authors:  J Scott Gabrielsen; Yan Gao; Judith A Simcox; Jingyu Huang; David Thorup; Deborah Jones; Robert C Cooksey; David Gabrielsen; Ted D Adams; Steven C Hunt; Paul N Hopkins; William T Cefalu; Donald A McClain
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

7.  Biomarkers of body iron stores and risk of developing type 2 diabetes.

Authors:  S N Rajpathak; J Wylie-Rosett; M J Gunter; A Negassa; G C Kabat; T E Rohan; J Crandall
Journal:  Diabetes Obes Metab       Date:  2009-01-21       Impact factor: 6.577

Review 8.  Dietary iron intake, iron status, and gestational diabetes.

Authors:  Cuilin Zhang; Shristi Rawal
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 9.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

10.  Long-term risk of type 2 diabetes in relation to habitual iron intake in women with a history of gestational diabetes: a prospective cohort study.

Authors:  Wei Bao; Jorge E Chavarro; Deirdre K Tobias; Katherine Bowers; Shanshan Li; Frank B Hu; Cuilin Zhang
Journal:  Am J Clin Nutr       Date:  2016-01-13       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.